In an MPN model, mice with Jak2V617F and Tet2 mutations had a more severe MPN phenotype, where double mutant HSPCs could maintain MPNs in secondary recipients after transplantation (Chen et al., 2015). The gene discussed is TET2; the disease is myeloproliferative neoplasm.